Molecular Pathogenesis of Philadelphia Chromosome Negative Chronic Myeloproliferative Neoplasms

Publisher： Bentham Science Publishers

E-ISSN： 1873-5576|11|1|20-30

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.11, Iss.1, 2011-01, pp. : 20-30

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Interferon-Alpha in the Treatment of Philadelphia-Negative Chronic Myeloproliferative Neoplasms. Status and Perspectives

By  

Current Drug Targets, Vol. 12, Iss. 3, 2011-01 ,pp. : 392-419

Bentham Science Publishers

Access to resources Recommend Favorite

Emerging therapies for the treatment of chronic Philadelphia chromosome-negative myeloproliferative neoplasm-associated myelofibrosis

By Gowin Krisstina   Mesa Ruben  

Expert Opinion on Investigational Drugs, Vol. 22, Iss. 12, 2013-12 ,pp. : 1603-1611

Informa Healthcare

Access to resources Recommend Favorite

Molecular Pathogenesis of Philadelphia-Positive Chronic Myeloid Leukemia - is it all BCR-ABL?

By  

Current Cancer Drug Targets, Vol. 11, Iss. 1, 2011-01 ,pp. : 3-19

Bentham Science Publishers

Access to resources Recommend Favorite

Immunotherapy for Myeloproliferative Neoplasms (MPN)

By  

Current Cancer Drug Targets, Vol. 11, Iss. 1, 2011-01 ,pp. : 72-84

Bentham Science Publishers

Access to resources Recommend Favorite

The Mevalonate Pathway as a Therapeutic Target in the Ph-Negative Chronic Myeloproliferative Disorders

By  

Current Drug Targets, Vol. 8, Iss. 2, 2007-02 ,pp. : 247-256

Bentham Science Publishers

Access to resources Recommend Favorite